Freedman S B, Poat J A, Woodruff G N
J Neurochem. 1981 Sep;37(3):608-12. doi: 10.1111/j.1471-4159.1982.tb12530.x.
[3H]Sulpiride bound to rat striatal membrane preparations with a saturable, high affinity component. This binding was displaced potently by dopamine antagonists (both classic neuroleptics and the benzamide, sulpiride) and less potently by dopamine agonists. GTP and its stable analogue Gpp(NH)p did not affect [3H]sulpiride binding to the membranes but altered the affinity for dopaminergic agonists. This effect was specific in that antagonist binding was not affected and only GTP, GDP, and Gpp(NH)p produced the effect. Similar alterations in ligand binding affinity caused by guanine nucleotides have been observed for binding sites linked to an adenylate cyclase. Such an interpretation for the case of [3H]sulpiride is contrary to suggestions that sulpiride labels only those dopamine receptors that are not cyclase linked.
[3H]舒必利与大鼠纹状体膜制剂结合,存在一个可饱和的高亲和力成分。这种结合被多巴胺拮抗剂(经典抗精神病药物和苯甲酰胺类舒必利)强力取代,被多巴胺激动剂取代的能力则较弱。鸟苷三磷酸(GTP)及其稳定类似物鸟苷-5'-三磷酸(Gpp(NH)p)不影响[3H]舒必利与膜的结合,但改变了对多巴胺能激动剂的亲和力。这种效应具有特异性,因为拮抗剂的结合不受影响,只有GTP、鸟苷二磷酸(GDP)和Gpp(NH)p产生这种效应。对于与腺苷酸环化酶相连的结合位点,鸟嘌呤核苷酸引起的配体结合亲和力的类似改变也已被观察到。对于[3H]舒必利这种情况的这种解释与舒必利仅标记那些不与环化酶相连的多巴胺受体的观点相反。